BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rosso C, Abate ML, Ciancio A, Strona S, Caviglia GP, Olivero A, Touscoz GA, Rizzetto M, Pellicano R, Smedile A. IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients. World J Gastroenterol 2014; 20(36): 13146-13152 [PMID: 25278709 DOI: 10.3748/wjg.v20.i36.13146]
URL: https://www.wjgnet.com/1948-5182/full/v20/i36/13146.htm
Number Citing Articles
1
Satish Kumar Sadasivan, Nethra Siddaraju, Khaiser Mehdi Khan, Balamuralikrishna Vasamsetti, Nimisha R Kumar, Vibha Haridas, Madhusudhan B Reddy, Somesh Baggavalli, Anup M Oommen, Raghavendra Pralhada Rao. Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slicesFibrogenesis & Tissue Repair 2015; 8(1) doi: 10.1186/s13069-014-0017-2
2
Fahu Yuan, Hualin Wang, Yu Tian, Qi Li, Lei He, Na Li, Zhiguo Liu. Fish oil alleviated high-fat diet–induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic studyLipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0190-y
3
Nirmal Kumar, Suchitra S. Prabhu, Isha Monga, Indranil Banerjee. Influence of IL28B gene polymorphisms on PegINF-RBV-mediated HCV clearance in HIV-HCV co-infected patients: A meta-analysisMeta Gene 2021; 29: 100909 doi: 10.1016/j.mgene.2021.100909
4
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
5
Normeen Hany Rady, Rania Kamal Darwish, Engy Adel Mogahed, Iman Atef Mandour, Hazem Abo Youssef, Sahar Abdel Atty Sharaf, Hanaa Mostafa El-Karaksy. Potential genetic markers for prediction of treatment response in Egyptian children infected with HCV genotype 4Cytokine 2015; 75(2): 349 doi: 10.1016/j.cyto.2015.04.005
6
Henrik H. Hansen, Gitte Hansen, Thomas Secher, Michael Feigh, Sanne S. Veidal, Keld Fosgerau, Jacob Jelsing, Niels Vrang. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 369 doi: 10.1007/978-3-030-11748-1_14
7
Jonathan D. Roth, Sanne S. Veidal, Louise K. D. Fensholdt, Kristoffer T. G. Rigbolt, Romeo Papazyan, Jens Christian Nielsen, Michael Feigh, Niels Vrang, Mark Young, Jacob Jelsing, Luciano Adorini, Henrik H. Hansen. Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASHScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45178-z
8
Valerio Caputo, Claudia Strafella, Terenzio Cosio, Caterina Lanna, Elena Campione, Giuseppe Novelli, Emiliano Giardina, Raffaella Cascella. Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of PsoriasisGenes 2021; 12(9): 1398 doi: 10.3390/genes12091398
9
Irwin K. Cheah, Richard Tang, Peng Ye, Terry S. Z. Yew, Keith H. C. Lim, Barry Halliwell. Liver ergothioneine accumulation in a guinea pig model of non-alcoholic fatty liver disease. A possible mechanism of defence?Free Radical Research 2016; 50(1): 14 doi: 10.3109/10715762.2015.1099642
10
Eva Juárez-Hernández, Norberto C. Chávez-Tapia, Misael Uribe, Varenka J. Barbero-Becerra. Role of bioactive fatty acids in nonalcoholic fatty liver diseaseNutrition Journal 2015; 15(1) doi: 10.1186/s12937-016-0191-8
11
Chiara Rosso, Gian Paolo Caviglia, Michela Ciruolo, Alessia Ciancio, Ramy Younes, Antonella Olivero, Chiara Giordanino, Giulia Troshina, Maria Lorena Abate, Mario Rizzetto, Rinaldo Pellicano, Giorgio M. Saracco, Elisabetta Bugianesi, Antonina Smedile. Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective studyMinerva Medica 2019; 110(5) doi: 10.23736/S0026-4806.19.06108-1
12
Salvatore Sutti, Stefania Bruzzì, Emanuele Albano. The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 updateExpert Review of Gastroenterology & Hepatology 2016; 10(2): 243 doi: 10.1586/17474124.2016.1111758
13
K. Shubham, L. Vinay, P. K. Vinod. Systems-level organization of non-alcoholic fatty liver disease progression networkMolecular BioSystems 2017; 13(9): 1898 doi: 10.1039/C7MB00013H
14
Raffaella Cascella, Claudia Strafella, Giuliana Longo, Mara Maccarone, Paola Borgiani, Federica Sangiuolo, Giuseppe Novelli, Emiliano Giardina. Pharmacogenomics of multifactorial diseases: a focus on psoriatic arthritisPharmacogenomics 2016; 17(8): 943 doi: 10.2217/pgs.16.20
15
Zahra Iranmanesh, Hamid Reza Mollaie, Seyed Alimohammad Arabzadeh, Mohammad Javad Zahedi, Mehdi Fazlalipour, Saeede Ebrahimi. Evaluation of the Frequency of the IL-28 Polymorphism (rs8099917) in Patients with Chronic Hepatitis C Using Zip Nucleic Acid Probes, Kerman, Southeast of IranAsian Pacific Journal of Cancer Prevention 2015; 16(5): 1919 doi: 10.7314/APJCP.2015.16.5.1919
16
Veronica Jarido, Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Joanne Thomson, Kristen Stephenson, Heather Francis. The emerging role of mast cells in liver diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 313(2): G89 doi: 10.1152/ajpgi.00333.2016
17
Veronica Marin, Gemma Odena, Kyle Poulsen, Claudio Tiribelli, Stefano Bellentani, Andrea Barchetti, Pau Sancho Bru, Natalia Rosso, Ramon Bataller, Laura E. Nagy. MIF Family Cytokines in Innate Immunity and Homeostasis2017; : 109 doi: 10.1007/978-3-319-52354-5_7
18
M Asnavandi, M Zargar, F Vaziri, F R Jamnani, S Gharibzadeh, A Fateh, S D Siadat. EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis CGenes & Immunity 2017; 18(3): 144 doi: 10.1038/gene.2017.12